CLINICAL_TRIALS
trial_result
· 2016-05-17
Clinical Trial Update: Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer [Phase 2]
Summary
Phase 2 study of exemestane and celecoxib in postmenopausal women at high risk for breast cancer. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Georgetown University | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2016-05-17